Top Markets
Coin of the day
SpyGlass Pharma, Inc. Common Stock SpyGlass Pharma, Inc. Common Stock

SpyGlass Pharma, Inc. Common Stock

SGP
株式のランク #10213
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to... SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.
株価
$26.13
最終同期: 2026-08-28
時価総額
$873.45M
変化(1日)
-2.99%
変化(1年)
-
US
取引 SpyGlass Pharma, Inc. Common Stock (SGP)

カテゴリー

SpyGlass Pharma, Inc. Common Stock(SGP)の配当利回りの履歴
SpyGlass Pharma, Inc. Common Stock(銘柄コード: SGP)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
SpyGlass Pharma, Inc. Common Stock(SGP)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)